TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191 | -89.3% | 22,857 | -68.0% | 0.02% | -91.0% |
| Q2 2023 | $1,777 | +253.3% | 71,518 | +114.1% | 0.18% | +256.0% |
| Q1 2023 | $503 | -67.8% | 33,411 | -74.7% | 0.05% | -74.2% |
| Q4 2022 | $1,560 | -99.3% | 131,893 | +234.2% | 0.19% | +525.8% |
| Q3 2022 | $234,000 | +21.9% | 39,466 | -12.8% | 0.03% | +6.9% |
| Q2 2022 | $192,000 | -68.1% | 45,281 | -28.3% | 0.03% | -64.2% |
| Q1 2022 | $601,000 | +194.6% | 63,184 | +488.1% | 0.08% | +211.5% |
| Q4 2021 | $204,000 | -39.1% | 10,744 | +66.8% | 0.03% | -52.7% |
| Q4 2020 | $335,000 | -2.3% | 6,442 | -89.5% | 0.06% | +19.6% |
| Q3 2019 | $343,000 | – | 61,115 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |